الاتحاد الأوروبي -
الأيسلاندية -
EMA (European Medicines Agency)
trodelvy
gilead sciences ireland uc - sacituzumab govitecan - breast neoplasms; triple negative breast neoplasms - Æxlishemjandi lyf - trodelvy as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (mtnbc) who have received two or more prior systemic therapies, including at least one of them for advanced disease.
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
entocort hart hylki með breyttan losunarhraða 3 mg
tillotts pharma gmbh - budesonidum inn - hart hylki með breyttan losunarhraða - 3 mg
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
nasacort nefúði, dreifa 55 míkróg/skammt
opella healthcare france s.a.s. - triamcinolonum acetóníð - nefúði, dreifa - 55 míkróg/skammt
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
dexavit stungulyf/innrennslislyf, lausn 4 mg/ml
vital pharma nordic aps - dexamethasonum natríumfosfat - stungulyf/innrennslislyf, lausn - 4 mg/ml
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
heparin leo (heparin leo) stungulyf, lausn 5000 a.e./ml
leo pharma a/s* - heparinum natricum inn - stungulyf, lausn - 5000 a.e./ml
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
exemestan actavis filmuhúðuð tafla 25 mg
actavis group ptc ehf. - exemestanum inn - filmuhúðuð tafla - 25 mg
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
fungyn (fluconazole portfarma) hart hylki 150 mg
alvogen ehf. - fluconazolum inn - hart hylki - 150 mg
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
fungyn (fluconazole portfarma) hart hylki 200 mg
alvogen ehf. - fluconazolum inn - hart hylki - 200 mg
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
fungyn (fluconazole portfarma) hart hylki 50 mg
alvogen ehf. - fluconazolum inn - hart hylki - 50 mg
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
opnol augndropar, lausn 1 mg/ml
karo pharma ab* - dexamethasonum fosfat - augndropar, lausn - 1 mg/ml